Perfil
Sarah Ankri is currently the Director at France Biotech Association since 2014.
Prior to this, she worked as the Chief Financial Officer at Théraclion SA from 2013 to 2014 and as the Vice President-Finance at Lysogene SA. She also worked as a Manager-Financial Audit at Ernst & Young Audit SAS (France).
Ms. Ankri completed her undergraduate degree from Institut National Agronomique Paris-Grignon.
Cargos activos de Sarah Ankri
| Empresas | Cargo | Inicio |
|---|---|---|
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Director/Miembro de la Junta | 12/06/2014 |
Antiguos cargos conocidos de Sarah Ankri.
| Empresas | Cargo | Fin |
|---|---|---|
Ernst & Young Audit SAS (France)
Ernst & Young Audit SAS (France) Miscellaneous Commercial ServicesCommercial Services Provides Auditing & Accounting Services | Comptroller/Controller/Auditor | - |
| LYSOGENE | Director Financiero/CFO | - |
| THERACLION | Director Financiero/CFO | - |
Formación de Sarah Ankri.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Institut National Agronomique Paris-Grignon
Institut National Agronomique Paris-Grignon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young Audit SAS (France)
Ernst & Young Audit SAS (France) Miscellaneous Commercial ServicesCommercial Services Provides Auditing & Accounting Services | Commercial Services |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Commercial Services |
Théraclion SA
Théraclion SA Medical SpecialtiesHealth Technology Manufactures and markets utlra sound medical products | Health Technology |
Lysogene SA
Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
- Bolsa de valores
- Insiders
- Sarah Ankri
















